Surgical Stapling Articles & Analysis
4 news found
NewGen Surgical Inc. announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label on all product lines. Managed by the U.S. Department of Agriculture (USDA), the BioPreferred Program is an initiative created by the 2002 Farm Bill (and recently reauthorized by the 2018 Farm Bill), to increase the development, purchase, and use of biobased products. ...
Food and Drug Administration (FDA) 510(k) clearance for the disposable, Gastro Intestinal Balloon Indicator (GIBI HD™) calibration tube for use in gastric and bariatric surgical procedures. The company expects U.S. commercial sales to begin in September 2022. ...
The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. ...
With these latest allowances, our IP portfolio has expanded to protect the use of our antimicrobial technology on a broad range of medical devices and implants, including orthopedic screws, hip and knee prostheses, cardiac implantable defibrillators and pacemakers, implantable neurovascular stimulators, venous access indwelling catheters, sutures, staples, and ...